glp-1/gip/glucagon receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Major physiological roles of GLP-1

+The effect of GLP-1R agonists on brain mechanism is less than 50% (relative to the control group and the AD group without GLP-1R agonists)

The medication regimen and medication-taking behavior should be reevaluated at regular intervals (every 3-6 months) and adjusted as needed to incorporate specific factors that impact the choice of treatment

The agency in October ended the tirzepatide injection shortage prematurely based on representations from drugmakers and incomplete data on demand for the compounded versions of the drug, Scott Brunner, CEO of Alliance for Pharmacy Compounding, another compounding industry group, said in a statement to ABC News

doi:10.1074/jbc.R113.534743 57

doi: 10.1056/NEJMoa1607141 12 HernandezAFGreenJBJanmohamedSD'AgostinoRBSrGrangerCBJonesNPet al

Although, according to the American Diabetes Association, metformin is generally considered the preferred first-line therapy for treating type 2 diabetes, individuals who are intolerant towards metformin can consider GLP-1